LIVE MARKET TRACKER :   BSE SENSEX   26638.11      |    NSE NIFTY 7954.35    
GLOBAL MARKETS :  NASDAQ 4569.622   -0.02%    |    FSI London 6809.42   -0.31%    |    NIKKEI Japan 15459.86   -0.48%
  USD GBP EUR CAD AUD INR
USD - 0.6034 0.759 1.0856 1.069 60.63
GBP 1.6574 - 1.258 1.7993 1.7717 100.4882
EUR 1.3177 0.7952 - 1.4305 1.4086 79.8922
CAD 0.9216 0.5561 0.6995 - 0.9851 55.875
AUD 0.9355 0.5645 0.7101 1.0156 - 56.72
INR 0.0165 0.01 0.0125 0.0179 0.0176 -
Indian-Commodity  :  Equity & Shares  :  Dr Reddy's Lab gains on introducing PamorelinO LA - cancer drug

Dr Reddy's Lab gains on introducing PamorelinO LA - cancer drug (10-Dec-2012)

Dr Reddy's Lab is currently trading at Rs. 1845.00, up by 6.65 points or 0.36% from its previous closing of Rs. 1838.35 on the BSE.

The scrip opened at Rs. 1844.80 and has touched a high and low of Rs. 1846.95 and Rs. 1833.70 respectively. So far 1923 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1850.00 on 06-Dec-2012 and a 52 week low of Rs. 1528.00 on 19-Jun-2012.

Last one week high and low of the scrip stood at Rs. 1850.00 and Rs. 1804.00 respectively. The current market cap of the company is Rs. 31,321 crore.

The promoters holding in the company stood at 25.56% while Institutions and Non-Institutions held 39.75% and 17.76% respectively.

Dr Reddy's Laboratories, has introduced PamorelinO LA in India under an exclusive marketing and sales agreement with Debiopharm Group, Switzerland. The company will import this drug in bulk from Debio Recherche Pharmaceutique and made available primarily to urologists and oncologists across India. PamorelinO LA is used for the treatment of locally advanced or metastatic, hormone-dependent prostate cancer.

Dr Reddy's is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the company offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, bio-similars, differentiated formulations and NCEs 


Top News Today
M&M, Hero MotoCorp and Tech Mahindra to see some action today
(27-Aug-2014)

M&M, Hero MotoCorp and Tech Mahindra to see some action todayMahindra Agribusiness, part of the farm to aerospace conglomerate Mahindra & Mahindra (M&M), is all set to enter the dairy segment through the inorganic route, with a focus on the pouched......click on news to read complete article.

RIL, SAIL and Tata Steel to see some action today
(21-Aug-2014)

RIL, SAIL and Tata Steel to see some action todayReliance Industries (RIL) is implementing a project to import 1.5 million tonnes of ethane to feed its crackers in India, taking advantage of the US shale gas revolution. The project will significantly......click on news to read complete article.

RBI's chief hopes record foreign exchange to act as cushion against rupee volatility
(12-Aug-2014)

RBIReserve Bank of India's governor, Raghuram Rajan has expressed hopes that record foreign exchange reserves would act as a cushion against rupee volatility when global interest rates begin to climb. He......click on news to read complete article.

International Stock News
US markets closed mostly up; S&P holds 2,000 mark
(28-Aug-2014)

US markets closed mostly up; S&P holds 2,000 markThe US markets closed mostly higher on Wednesday, with the S&P 500 staying around 2,000 a day after it closed over that milestone. Global markets are surmounting crises in Ukraine, the Gaza Strip......click on news to read complete article.

US markets gain; S&P close above 2,000 for the first time
(27-Aug-2014)

US markets gain; S&P close above 2,000 for the first timeThe US markets closed higher on Tuesday, with the S&P 500 notching it's first-ever finish above the milestone level of 2,000. A stronger-than-expected reading on consumer confidence provided a......click on news to read complete article.

US markets gain; S&P jumps to record close
(26-Aug-2014)

US markets gain; S&P jumps to record closeThe US markets closed higher on Monday, with the S&P 500 climbing to a record close just shy of 2,000, as stocks received a lift from deal activity and hints of more stimulus from the European......click on news to read complete article.

 

     
  
Recent Equity & Shares News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.